HER2 positivity was also found enriched among DUSP6high tumors based on HER2 immunohistochemistry of samples available for staining in the Breast Invasive Carcinoma (TCGA, Firehose legacy) dataset (Dataref: Cerami et al, 2012; de Bruijn et al, 2023; Gao et al, 2013) (Appendix Fig. S2C). The gene discussed is ERBB2; the disease is invasive breast carcinoma.